- Home
- INM vs MTNB Comparison
INM vs MTNB Comparison
Compare INM & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- MTNB
- Stock Information
- Founded
- INM 1981
- MTNB 2013
- Country
- INM Canada
- MTNB United States
- Employees
- INM N/A
- MTNB N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- MTNB Health Care
- Exchange
- INM Nasdaq
- MTNB Nasdaq
- Market Cap
- INM 3.2M
- MTNB 3.6M
- IPO Year
- INM N/A
- MTNB N/A
- Fundamental
- Price
- INM $2.75
- MTNB $1.00
- Analyst Decision
- INM
- MTNB Hold
- Analyst Count
- INM 0
- MTNB 1
- Target Price
- INM N/A
- MTNB N/A
- AVG Volume (30 Days)
- INM 5.7M
- MTNB 354.9K
- Earning Date
- INM 05-12-2025
- MTNB 08-13-2025
- Dividend Yield
- INM N/A
- MTNB N/A
- EPS Growth
- INM N/A
- MTNB N/A
- EPS
- INM N/A
- MTNB N/A
- Revenue
- INM $4,920,990.00
- MTNB N/A
- Revenue This Year
- INM N/A
- MTNB N/A
- Revenue Next Year
- INM N/A
- MTNB N/A
- P/E Ratio
- INM N/A
- MTNB N/A
- Revenue Growth
- INM N/A
- MTNB N/A
- 52 Week Low
- INM $1.72
- MTNB $0.47
- 52 Week High
- INM $15.70
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- INM 46.31
- MTNB 63.74
- Support Level
- INM $2.66
- MTNB $0.88
- Resistance Level
- INM $2.97
- MTNB $1.05
- Average True Range (ATR)
- INM 0.37
- MTNB 0.07
- MACD
- INM -0.05
- MTNB 0.00
- Stochastic Oscillator
- INM 15.12
- MTNB 86.34
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.